Nursing care for patients with esophageal cancer receiving radiotherapy with pulmonary embolism: case study
Keywords:
Patients with esophageal cancer, pulmonary embolism, radiotherapyAbstract
This case study aims to study nursing. Esophageal cancer patients receiving radiotherapy with Pulmonary Embolism. The results of the study found that a Thai male patient aged 49 years presented with significant symptoms. Around April 2023, there was occasional vomiting after eating. In May 2022, it began to occur more frequently, weight decreased. Went for examination at Chao Phraya Yommarat Hospital, Suphanburi Province, performed CT chest (29 June 2023): long segmental circumferential irregular enhancing wall. thickening with luminal narrowing of mid to distal esophagus, about 11 cm. in length, 4.3 x 3.1 cm. in trans axial dimension EGD with Bx.: well differentiated squamous cell carcinoma, refer to Lopburi Cancer Hospital, found a radiologist, plan RT 25 Fx/4500 cGy. 1 September 2023 The patient came for an appointment to start RT. It was found that the patient had swelling in the face and left arm. CXR:: Suspected mediastinal adenopathy. Minimal reticular opacity in RUL field and haziness in both lower lung. possibly pneumonitis Venous thrombosis risk PE, therefore give Enoxaparin 0.6 ml sc OD and continue until discharge for another 30 days, in which the patient can receive radiation therapy, complete 25 Fx/4,500 cGy. according to the treatment plan and receive preparation. Distribution planning and continuous care in the community Completely including the duration of receiving medical treatment. From 1 September 2023 to 11 October 2023, a total of 40 days.
References
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893–917.
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225–49.
Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349: 2241–52.
Lepage C, Rachet B, Jooste V, Faivre J, Coleman MP. Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am J Gastroenterol 2008; 103: 2694–99.
Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005; 97: 142–46.
Imsamran W, Chaiwerawattana A, Wiangnon S, et al. Cancer in Thailand. Volume VIII, 2010- 2012.
Lagergren J, Bergstrom R, Lindgren A, Nyren O. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer 2000;85:340-346.
Engel LS, Chow W-H, Vaughan TL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003;95:1404-1413.
Freedman ND, Abnet CC, Leitzmann MF, et al. A prospective study of tobacco, alcohol, and the risk of sophageal and gastric cancer subtypes. Am J Epidemiol 2007;165:1424-1433
Turati F, Tramacere I, La Vecchia C, Negri E. A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma. Ann Oncol 2013;24:609-617.
Lagergren J, Lagergren P. Recent developments in esophageal adenocarcinoma. CA Cancer J Clin 2013;63:232-248.
Cossentino MJ, Wong RK. Barrett's esophagus and risk of esophageal adenocarcinoma. Semin Gastrointest Dis 2003;14:128-135.
Cameron AJ, Romero Y. Symptomatic gastro-oesophageal reflux as a risk factor for oesophageal adenocarcinoma. Gut 2000;46:754-755.
